COMMUNIQUÉS West-GlobeNewswire
-
She Had No Clue, Until She Did: Clue's new campaign spotlights seven women who found the missing piece behind years of symptoms, questions and hormonal uncertainty
01/07/2026 -
Compass Health recognized as a Quasquicentennial Corporation, marking 125 Years of service in Northwest Washington
01/07/2026 -
Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026
01/07/2026 -
Correction: Abivax annonce la fixation du prix de l’Offre au public largement sursouscrite de 800 M$ (702 M€) d’American Depositary Shares
01/07/2026 -
Medline to report second quarter 2026 results on August 5, 2026
01/07/2026 -
Daré Bioscience Announces Flora Sync LF5™ Is Now Available Through Its Direct-to-Consumer Platform
01/07/2026 -
Chemed To Report Second Quarter 2026 Earnings July 28, Related Conference Call To Be Held On July 29
01/07/2026 -
Abivax annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
01/07/2026 -
Amoéba obtient l’autorisation de mise sur le marché en France pour son biofongicide AXPERA
01/07/2026 -
ORYZON Raises €12 Million and Signs a Financing Agreement with COFIDES to Strengthen its Balance Sheet and Accelerate its Clinical Programs
01/07/2026 -
Correction: Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
01/07/2026 -
PolarityBio Announces Submission of its Biologics License Application for SkinTE® for the Treatment of Wagner Grade 1 Diabetic Foot Ulcers
01/07/2026 -
Managing Mental Health During the Summer
01/07/2026 -
Creative Medical Technology Holdings Issues Mid-Year Update
01/07/2026 -
NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes
01/07/2026 -
Amoéba has received marketing authorization in France for its biofungicide AXPERA
01/07/2026 -
Abivax announces trading resumption of its ordinary shares on Euronext Paris
01/07/2026 -
How Meaningful Work Supports Long-Term Sobriety
01/07/2026 -
Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace
01/07/2026
Pages